Education
About Us
Working with TipRanks
Follow Us
PT Kalbe Farma Tbk (PTKFY)
OTHER OTC:PTKFY
Total Valuation
PT Kalbe Farma Tbk has a market cap or net worth of $3.45B. The enterprise value is $3.73B.
Market Cap$3.45B
Enterprise Value$3.73B
Share Statistics
PT Kalbe Farma Tbk has 234.38M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding234.38M
Owned by Insiders
Owned by Instutions0.03%
Financial Efficiency
PT Kalbe Farma Tbk’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 11.52%.
Return on Equity (ROE)12.92%
Return on Assets (ROA)10.23%
Return on Invested Capital (ROIC)11.52%
Return on Capital Employed (ROCE)15.25%
Revenue Per Employee$2,485,831,816.395
Profits Per Employee$238,331,904.06
Employee Count12,924
Asset Turnover1.13
Inventory Turnover2.74
Valuation Ratios
The current PE Ratio of PT Kalbe Farma Tbk is 7.49K. PT Kalbe Farma Tbk’s PEG ratio is -75.21.
PE Ratio7.49K
PS Ratio680.55
PB Ratio967.48
Price to Fair Value967.48
Price to FCF11.99K
Price to Operating Cash Flow7.13K
PEG Ratio-75.21
Income Statement
In the last 12 months, PT Kalbe Farma Tbk had revenue of $32.13T and earned $3.08T in profits. Earnings per share was $13324.48.
Revenue$32.13T
Gross Profit$12.12T
Operating Income$3.92T
Pretax Income$4.05T
Net Income$3.08T
EBITDA4.75T
Earnings Per Share (EPS)13.32K
Cash Flow
In the last 12 months, operating cash flow was $5.04T and capital expenditures -$1.39T, giving a free cash flow of $3.61T billion.
Operating Cash Flow$5.04T
Free Cash Flow$3.61T
Free Cash Flow per Share$15.38K
Dividends & Yields
PT Kalbe Farma Tbk pays an annual dividend of $0.27, resulting in a dividend yield of 1.80%
Dividend Per Share$0.27
Dividend Yield1.80%
Payout Ratio30.64%
Free Cash Flow Yield<0.01%
Earnings Yield0.01%
Stock Price Statistics
Beta0.27
52-Week Price Change-19.58%
50-Day Moving Average14.07
200-Day Moving Average18.22
Relative Strength Index (RSI)49.89
Average Volume (3m)60.00
Important Dates
PT Kalbe Farma Tbk upcoming earnings date is Apr 24, 2025, TBA.
Last Earnings DateMar 28, 2025
Next Earnings DateApr 24, 2025
Ex-Dividend DateMay 31, 2024
Financial Position
PT Kalbe Farma Tbk as a current ratio of 4.91, with Debt / Equity ratio of 0.03
Current Ratio4.91
Quick Ratio2.81
Debt to Market Cap<0.01
Net Debt to EBITDA-0.65
Interest Coverage Ratio43.77
Taxes
In the past 12 months, PT Kalbe Farma Tbk has paid $945.75B in taxes.
Income Tax$945.75B
Effective Tax Rate23.47%
Enterprise Valuation
PT Kalbe Farma Tbk EV to EBITDA ratio is 5.15K, with an EV/FCF ratio of 11.99K.
EV to Sales680.47
EV to EBITDA5.15K
EV to Free Cash Flow11.99K
EV to Operating Cash Flow7.13K
Balance Sheet
PT Kalbe Farma Tbk has $4.32T in cash and marketable securities with $740.96B in debt, giving a net cash position of -$3.58T billion.
Cash & Marketable Securities$4.32T
Total Debt$740.96B
Net Cash-$3.58T
Net Cash Per Share-$15.26K
Tangible Book Value Per Share$461.39
Margins
Gross margin is 38.83%, with operating margin of 11.92%, and net profit margin of 9.09%.
Gross Margin38.83%
Operating Margin11.92%
Pretax Margin11.92%
Net Profit Margin9.09%
EBITDA Margin13.21%
EBIT Margin12.12%
Analyst Forecast
The average price target for PT Kalbe Farma Tbk is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast3.34%
EPS Growth Forecast13.35%